Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
SpyCEP dismantles neutrophil immunity via disorder-driven chemokine remodeling and GAG targeting.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 09, 2026
Evidence for a Two-Step Model for Activation of GPR25 by the Chemoattractant CXCL17.
Journal: Basic & clinical pharmacology & toxicology
Published: March 10, 2026
The small ubiquitin-like modifier SUMO-3 acts as a neutrophil chemoattractant via the chemokine receptors CXCR1 and CXCR2.
Journal: Journal of innate immunity
Published: January 08, 2026
The N-terminal ELR+ motif of the neutrophil attractant CXCL8 confers susceptibility to degradation by the Group A streptococcal protease, SpyCEP.
Journal: The Journal of biological chemistry
Published: October 16, 2024
The chemokine receptor CCR8 is not a high-affinity receptor for the human chemokine CCL18.
Journal: PloS one
Published: May 28, 2024
Atypical chemoattractants and their receptors: A potential gateway to novel therapeutic strategies.
Journal: Cytokine
Published: March 27, 2024
CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling.
CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling.
Journal: Frontiers in immunology
Published: July 07, 2023
The protease associated (PA) domain in ScpA from Streptococcus pyogenes plays a role in substrate recruitment.
Journal: Biochimica et biophysica acta. Proteins and proteomics
Published: May 30, 2023
What defines a chemokine? - The curious case of CXCL17.
Journal: Cytokine
Published: February 24, 2023
Matrix Metalloproteinase-12 Supports Pulmonary B Cell Follicle Formation and Local Antibody Responses During Asthma.
Journal: American journal of respiratory and critical care medicine
Published: August 09, 2022
Last Updated: 09/26/2026